Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical intestinal transplantation.

H Furukawa1, J Reyes, K Abu-Elmagd

  • 1Pittsburgh Transplantation Institute, University of Pittsburgh, 4C Falk Clinic, 3601 Fifth Avenue, Pittsburgh, PA 15213, USA.

Clinical Nutrition (Edinburgh, Scotland)
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A case of Creutzfeldt-Jakob disease with a point mutation at codon 232: correlation of MRI and neurologic findings.

Neurology·1997
Same author

Suppressing effects of S-methyl methanethiosulfonate and diphenyl disulfide on mitomycin C-induced somatic mutation and recombination in Drosophila melanogaster and micronuclei in mice.

Mutation research·1997
Same author

Association of cumulative allelic losses with tumor aggressiveness in hepatocellular carcinoma.

Journal of hepatology·1997
Same author

Graft-versus-host disease after liver and small bowel transplantation in a child.

Clinical transplantation·1997
Same author

Metastatic renal cell carcinoma to the gallbladder: color Doppler sonography and CT findings.

AJR. American journal of roentgenology·1997
Same author

Beta-cell lines derived from transgenic Cpe(fat)/Cpe(fat) mice are defective in carboxypeptidase E and proinsulin processing.

Endocrinology·1997

Tacrolimus enables intestinal transplantation for irreversible intestinal failure. Despite challenges with infections and immune issues, this procedure offers a viable option for patients, with survival rates improving over time.

Area of Science:

  • Gastroenterology and Hepatology
  • Transplant Surgery
  • Immunology

Background:

  • Intestinal transplantation is a complex procedure for patients with irreversible intestinal failure.
  • Tacrolimus has been a key immunosuppressant enabling the success of intestinal transplantation.
  • Significant challenges remain, including infectious complications and immunological issues.

Purpose of the Study:

  • To present clinical experience and an overview of intestinal transplantation outcomes.
  • To highlight the role of tacrolimus in enabling this procedure.
  • To discuss the major causes of morbidity and mortality in intestinal transplant recipients.

Main Methods:

  • Retrospective analysis of 71 intestinal transplantation cases over the last 5 years.

Related Experiment Videos

  • Categorization of grafts: isolated intestinal, combined liver-intestinal, and multivisceral.
  • Inclusion of colon in the graft was noted in 29 patients.

    • Main Results:

    • Overall patient survival rates at 1, 2, and 4 years were 72%, 57%, and 45%, respectively.
    • A total of 71 patients, including 41 children and 30 adults, underwent transplantation.
    • Infectious and immunological complications were identified as major contributors to morbidity and mortality.

    Conclusions:

    • Intestinal transplantation, facilitated by tacrolimus, is a feasible treatment for intestinal failure.
    • Managing infectious and immunological complications is critical for improving patient survival.
    • This experience underscores the importance of addressing post-transplant complications to enhance outcomes.